These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11489557)

  • 1. Influence of various drugs on the glass transition temperature of poly(vinylpyrrolidone): a thermodynamic and spectroscopic investigation.
    Nair R; Nyamweya N; Gönen S; Martínez-Miranda LJ; Hoag SW
    Int J Pharm; 2001 Aug; 225(1-2):83-96. PubMed ID: 11489557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relating hydrogen-bonding interactions with the phase behavior of naproxen/PVP K 25 solid dispersions: evaluation of solution-cast and quench-cooled films.
    Paudel A; Nies E; Van den Mooter G
    Mol Pharm; 2012 Nov; 9(11):3301-17. PubMed ID: 23009610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
    Xiang TX; Anderson BD
    J Pharm Sci; 2013 Mar; 102(3):876-91. PubMed ID: 23280486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluate the ability of PVP to inhibit crystallization of amorphous solid dispersions by density functional theory and experimental verify.
    Wang B; Wang D; Zhao S; Huang X; Zhang J; Lv Y; Liu X; Lv G; Ma X
    Eur J Pharm Sci; 2017 Jan; 96():45-52. PubMed ID: 27568852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Water vapor absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions.
    Crowley KJ; Zografi G
    J Pharm Sci; 2002 Oct; 91(10):2150-65. PubMed ID: 12226842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical and experimental investigation on the solid solubility and miscibility of naproxen in poly(vinylpyrrolidone).
    Paudel A; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2010 Aug; 7(4):1133-48. PubMed ID: 20524682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental, Thermodynamic, and Molecular Modeling Evaluation of Amorphous Simvastatin-Poly(vinylpyrrolidone) Solid Dispersions.
    Kapourani A; Chatzitheodoridou M; Kontogiannopoulos KN; Barmpalexis P
    Mol Pharm; 2020 Jul; 17(7):2703-2720. PubMed ID: 32520564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
    van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(2-Ethyl-2-Oxazoline) as an Alternative to Poly(Vinylpyrrolidone) in Solid Dispersions for Solubility and Dissolution Rate Enhancement of Drugs.
    Fael H; Ràfols C; Demirel AL
    J Pharm Sci; 2018 Sep; 107(9):2428-2438. PubMed ID: 29859957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of physical properties of troglitazone crystal on the molecular interaction with PVP during heating.
    Hasegawa S; Furuyama N; Yada S; Hamaura T; Kusai A; Yonemochi E; Terada K
    Int J Pharm; 2007 May; 336(1):82-9. PubMed ID: 17178201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of poly(vinylpyrrolidone) with ibuprofen and naproxen: experimental and modeling studies.
    Bogdanova S; Pajeva I; Nikolova P; Tsakovska I; Müller B
    Pharm Res; 2005 May; 22(5):806-15. PubMed ID: 15906177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.
    Matsumoto T; Zografi G
    Pharm Res; 1999 Nov; 16(11):1722-8. PubMed ID: 10571278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective.
    Gupta P; Kakumanu VK; Bansal AK
    Pharm Res; 2004 Oct; 21(10):1762-9. PubMed ID: 15553220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can compression induce demixing in amorphous solid dispersions? A case study of naproxen-PVP K25.
    Ayenew Z; Paudel A; Van den Mooter G
    Eur J Pharm Biopharm; 2012 May; 81(1):207-13. PubMed ID: 22293573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
    Mol Pharm; 2017 Jan; 14(1):157-171. PubMed ID: 28043133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular interactions in celecoxib-PVP-meglumine amorphous system.
    Gupta P; Bansal AK
    J Pharm Pharmacol; 2005 Mar; 57(3):303-10. PubMed ID: 15807985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of lutein-loaded particles for improving solubility and stability by Polyvinylpyrrolidone (PVP) as an emulsion-stabilizer.
    Zhao C; Cheng H; Jiang P; Yao Y; Han J
    Food Chem; 2014 Aug; 156():123-8. PubMed ID: 24629947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.
    Sethia S; Squillante E
    Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates.
    Yoshioka M; Hancock BC; Zografi G
    J Pharm Sci; 1995 Aug; 84(8):983-6. PubMed ID: 7500284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.